Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?


Bristol Myers Squibb (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) compete against each other in the marketplace every day. However, the two big drugmakers are also working together to develop a new blood thinner. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the prospects for this experimental drug.

Continue reading


Source Fool.com

Like: 0
BMY
Share

Comments